Colonis specialise in the development, regulatory approval and commercialisation of medicines that are currently unlicensed but have an existing patient need and prescriber demand. Colonis are dedicated to making medicines more manageable for patients and healthcare professionals.
We also offer a range of out-licensing and export opportunities for our portfolio. In addition to this, our business development team are continuously looking for complementary in-licensing options.
You are now leaving the Colonis website. You have selected a link that will take you to a site maintained by a third party who is solely responsible for its contents. Colonis is not responsible for the privacy policy of any third party websites. We encourage you to read the privacy policy of every website you visit. Select Continue to proceed or Cancel to remain on the Colonis site.